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Abstract: Leishmaniasis is a protozoan vector-borne disease and is one of the biggest health 
problems of the world. Antileishmanial drugs have disadvantages such as toxicity and the recent 
development of resistance. One of the best-known mechanisms of the antibacterial effects of 
silver nanoparticles (Ag-NPs) is the production of reactive oxygen species to which Leishmania 
parasites are very sensitive. So far no information about the effects of Ag-NPs on Leishmania 
tropica parasites, the causative agent of leishmaniasis, exists in the literature. The aim of this 
study was to investigate the effects of Ag-NPs on biological parameters of L. tropica such as 
morphology, metabolic activity, proliferation, infectivity, and survival in host cells, in vitro. 
Consequently, parasite morphology and infectivity were impaired in comparison with the   control. 
Also, enhanced effects of Ag-NPs were demonstrated on the morphology and infectivity of 
parasites under ultraviolet (UV) light. Ag-NPs demonstrated significant antileishmanial effects 
by inhibiting the proliferation and metabolic activity of promastigotes by 1.5- to threefold, 
respectively, in the dark, and 2- to 6.5-fold, respectively, under UV light. Of note, Ag-NPs 
inhibited the survival of amastigotes in host cells, and this effect was more significant in the 
presence of UV light. Thus, for the first time the antileishmanial effects of Ag-NPs on L. tropica 
parasites were demonstrated along with the enhanced antimicrobial activity of Ag-NPs under UV 
light. Determination of the antileishmanial effects of Ag-NPs is very important for the further 
development of new compounds containing nanoparticles in leishmaniasis treatment.
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Introduction
Leishmaniasis is one of the serious health problems of the world. It is currently endemic 
in 98 countries worldwide. Overall annual prevalence of the disease is approximately 
12 million people and the size of the population at risk is approximately 350 million. 
It is estimated that approximately 1.5 million new cases of cutaneous leishmaniasis 
and 500,000 cases of visceral leishmaniasis occur worldwide each year.1,2 Furthermore, 
incidents of leishmaniasis are reported to be on the rise because of an increase in the 
number of vectors of the disease due to global warming.3,4
Among several drugs used in the treatment of leishmaniasis, pentavalent anti-
monials, considered a gold standard in the treatment, are known to be very toxic to 
humans.5–9 Resistance to antileishmanial drugs has also been observed in Leishmania 
parasites.10 Furthermore, as the drugs used in treatment are so expensive, their use 
is mostly limited in undeveloped and developing countries. Ineffectiveness of drugs 
against several species of Leishmania is another disadvantage.11 For these reasons, new 
approaches in the treatment of leishmaniasis are urgently needed.12,13International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Currently, the interest in nanotechnological approaches 
in microbiology is growing rapidly, as in all fields of the 
science.14 The main motive is the expectation that nano-
particles will be able to be used in the treatment of various 
diseases in the future.15–17 In recent studies it was determined 
that through their unique properties and large surface areas, 
metal oxide nanoparticles possess effective antimicrobial 
activities.18 Particularly, owing to their great chemical 
reactivity, nanoparticles are capable of producing reactive 
oxygen species (ROS), which have the ability to kill infec-
tious agents.
The antibacterial and antiviral behaviors of silver,   silver 
ions, and silver-containing compounds have long been 
investigated.19–21 The catalytic oxidation caused by   metallic 
silver and reactions with dissolved single-valent silver ions 
are thought to contribute to its bactericidal effects within 
bacterial cells. However, some bacteria have recently shown 
resistance to the action of silver compounds, similar to 
resistance to traditional antibiotics.22 On the other hand, 
promising results were recently reported with respect to the 
antimicrobial effect of nanoparticles by themselves or within 
composites.23,24 Several studies have reported that silver 
nanoparticles (Ag-NPs) showed high efficacy in inactivating 
bacteria and viruses.25–28
As mentioned, the basis for the antimicrobial effect 
of nanoparticles is their ability to produce ROS.29 
  Leishmania parasites are also known to be sensitive to 
ROS.30   Macrophages, being host cells for Leishmania 
parasites, can produce high amounts of ROS in order to kill 
microbial agents.31 However, this production is prevented 
by Leishmania through the inhibition of the enzymatic 
mechanism responsible for producing ROS, and Leishmania 
can survive inside macrophages without being exposed to 
any damage.32 Therefore, it may be posited that in order to 
inhibit Leishmania parasites with a ROS-based treatment, 
these oxygen derivatives must be produced in a physical 
way such as through Ag-NPs, instead of in an enzymatic 
way that can be blocked by parasites. The authors hypoth-
esize that Ag-NPs, with their unique properties including 
the ability to produce high amounts of ROS independently 
of the host cells, can be used as an effective agent in the 
treatment of leishmaniasis.
In a previous study, Butkus et al33 explored the effects 
of silver ions, obtained from silver nitrate (AgNO3, Merck, 
Darmstadt, Germany), and ultraviolet (UV) light on the bac-
terial virus MS2 and demonstrated that while silver ions and 
UV together exert a synergistic effect in inactivating viruses, 
UV light by itself did not have such an effect. The present 
authors consider that the antimicrobial effects of Ag-NPs, 
which are capable of releasing silver ions, may be enhanced 
by irradiation with UV light. However, no examples of an 
antimicrobial effect of Ag-NPs under UV light can be found 
in the literature.
Therefore, the aim of this study was to investigate 
in vitro antileishmanial effects of Ag-NPs on morphology 
and various cellular biological activities including growth, 
metabolic activity, proliferation, infectivity, and infection 
index of Leishmania tropica parasites both in the presence 
and in the absence of UV light. Results showed that Ag-NPs 
demonstrate an antileishmanial effect alone by inhibiting all 
biological activities of L. tropica parasites and that this effect 
was increased further under UV light.
Material and methods
Preparation and characterization  
of Ag-NPs
To produce Ag nanopowder, initially sodium hydroxide solu-
tion (1 mol/L, 300 mL, [Merck, Darmstadt, Germany] and 
AgNO3 solution (0.5 mol/L, 500 mL) were mixed with the 
help of magnetic stirring. As a result, a brown precipitate 
with pH 10 was observed. Following this, 5 mL of sodium 
dodecyl sulfate solution (Merck, Darmstadt, Germany) 
1 mol/L was added and mixed until a homogeneous solu-
tion was obtained. Consequently, 3 mL of hydrazine hydrate 
(Merck, Hohenbrunn, Germany) was added drop-wise. After 
the washing step with distilled water, the solution was dried 
at 80°C for 48 hours and finally was calcined at 350°C for 
2 hours.
The solution of Ag-NPs (1 mg/mL) was prepared in 
distilled water. The solution was mixed by vortexing for 
1–2 minutes and was sonicated for 30 minutes in order to 
disperse aggregates. After sonication, the solution was auto-
claved and was again mixed by vortexing before each use.
The collected Ag-NPs were characterized by transmission 
electron microscopy and their size and morphology were 
assessed. For characterization, nanoparticle powders were 
diluted in pure acetone and the prepared suspension was ultra-
sonicated. The suspension was put drop-wise on   carbon-coated 
copper grids and dried. Transmission electron microscopy 
characterization of the Ag-NPs was performed using a JEOL-
1010 microscope (Jeol Korea Ltd, Korea).
To measure the hydrodynamic size of the nanoparticles 
in dynamic light scattering (DLS), 100 µL of the particle 
solution was diluted with 1.5 mL of water and placed into the 
cuvette of a Zetasizer Nano instrument (Malvern   Instruments 
Ltd, Philadelphia, PA). Experiments were conducted in tripli-
cate to obtain an average number-size distribution. The same 
apparatus was used to measure zeta potentials.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cell culture
L. tropica promastigotes (MHOM/TR/99/EP39) were   cultured 
in RPMI-1640 medium with L-glutamine (Sigma, St Louis, 
MO) supplemented with 10% fetal calf serum (FCS) (Sigma, 
St Louis, MO). Parasites were passaged weekly by transfer-
ring 3 × 105 promastigotes from   previous culture to 5 mL 
of RPMI-1640 plus 10% FCS medium. The   cultivation of 
J774 macrophage cells (kindly obtained from Professor 
Ayhan Bilir, Istanbul University, School of Medicine, 
Histology and Embryology Department) was maintained 
in RPMI-1640 medium with L-glutamine plus 10% FCS. 
  Macrophage cells (5 × 105 cells/mL) were added to a flask con-
taining 5 mL of RPMI-1640 plus 10% FCS medium and the 
flask was incubated at 37°C. Cells were passaged weekly.
giemsa staining
Parasite cultures (10–20 µL) that had been exposed to 
  Ag-NPs in test tubes in the dark and under UV light were 
spread on microscope slides. These slides were then fixed in 
methanol for 5 minutes. After fixation, Giemsa stain (Sigma, 
St Louis, MO) was applied to the slides for 45 minutes 
and they were then examined with an inverted microscope 
(magnification 20×) (Olympus CK40; Olympus, Japan).
5-diphenyl-tetrazolium bromide assay
The effects of different concentrations of Ag-NPs (25, 50, 100, 
150, and 200 µg/mL) on the viability of L. tropica parasites 
in the dark and under UV light were determined by the 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyl-  tetrazolium   bromide 
(MTT) assay. For each determination, two microplates (TPP, 
Zurich, Switzerland) were used. After the addition of different 
concentrations of Ag-NPs into the wells, one of the microplates 
was exposed to UV light (36 W PL-L; Philips, Somerset, NJ) 
while the other was held in the dark for 1 hour. The microplates 
were then incubated at 27°C for 48 hours. After incubation, 
10 µL of MTT solution (10 mg/mL) was added to all of 
the wells and the microplates were then incubated at 27°C 
for 4 hours. Generation of formazan crystals was observed 
microscopically while cell viability values were determined 
quantitatively using a microplate reader (Fluoroskan Ascent, 
Thermo Labsystems, Helsinki, Finland) at 570 nm.
Determination of effects of Ag-NPs  
on proliferation of parasites
Determinations were carried out in culture of L. tropica pro-
mastigotes. Every assay tube contained 3 mL of medium with 
1 × 106 parasites/mL of L. tropica promastigotes. Assays were 
divided into two groups: the first group was exposed to UV 
light, whereas the second group was held in the dark. Control 
Leishmania culture was not exposed to Ag-NPs. Exposure to 
UV light lasted for 1 hour, and following that, each test tube was 
incubated at 27°C. Parasites were counted by hemocytometer 
(Marienfeld, Germany) at 24, 48, and 72 hours of incubation.
Determination of effects of Ag-NPs  
on infectivity of parasites
To investigate the infectivity of L. tropica promastigotes exposed 
to Ag-NPs (100 µg/mL), J774 cells (5 × 104) were seeded into 
a six-well plate (TPP, Zurich, Switzerland) that had coverslips 
within each well. At the same time, Leishmania parasites 
(1 × 106 parasites/mL) were seeded into six experimental tubes. 
Three of the tubes were exposed to Ag-NPs (100 µg/mL): the 
first tube was kept under the dark condition; the second was kept 
under visible light; and the last one was exposed to UV light. 
The remaining three tubes were used as controls. After 24 hours 
of incubation, 5 × 105 promastigotes from the experiment were 
added to each well of the six-well plate with a ratio of 10 pro-
mastigotes to each macrophage. The plate was then incubated 
at 37°C for 3–4 hours. After incubation, each well of the plate 
was rinsed with 1–2 mL phosphate-buffered saline (PBS) 
(Sigma, St Louis, MO) in order to remove non-phagocytized 
  promastigotes. The plate was then incubated again at 37°C 
overnight and 24 hours later each sample from the experimental 
plates was stained with Giemsa. Infectivity was determined 
using an inverted microscope (magnification 100×).
cytotoxicity evaluation
For the cytotoxicity assay, a suspension of 2.5 × 105 
J774   macrophages in RPMI-1640 medium, supplemented 
with 10% FCS and 1% penicillin (10000 UI/mL)/  streptomycin 
(10 mg/mL) were added to each well of 96-well plates. The 
plates were incubated at 37°C for 24 hours for adhesion of mac-
rophages to the bottom of the well. The nonadherent cells were 
removed by washing with the RPMI-1640 medium. Then differ-
ent concentrations of Ag-NPs (in the range from 1 to 500 µg/mL) 
were added to wells and one of the plates was held in dark, while 
the other was exposed to UV light. After 30 minutes, the plates 
were incubated at 37°C for 48 hours. Then 10 µL of MTT was 
added to each well at concentration of 10 mg/mL, followed by 
incubation for 4 hours. After that, 100 µL of dimethyl sulfoxide 
(AppliChem, Darmstadt, Germany) was added to each well and 
the contents of each well were homogenized for 15 minutes with 
subsequent determination of the absorbance at 570 nm.
Antileishmanial activity against 
amastigotes
Ag-NPs that were found to eliminate L. tropica promastigotes 
in the initial microscope-based studies were further tested International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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to compare their leishmanicidal activities with amastigotes. 
J774 macrophage cells 2, 5 × 105 cells/mL were seeded in 
24-well plates and allowed to adhere for 4 hours at 37°C and 
5% CO2. Nonadherent cells were washed with PBS, and the 
macrophages were incubated overnight in RPMI-1640 media. 
Adherent macrophages were infected with L. tropica promas-
tigotes at a parasite/macrophage ratio of 10:1 and incubated at 
37°C in 5% CO2 for 4 hours. Free promastigotes were removed 
by washing the wells with PBS and nanoparticles in different 
dilutions (in the range of 1 to 200 µg/mL) were then added to the 
wells. After 24 hours, chamber slides were fixed with methanol, 
stained with 10% Giemsa, and examined using oil-immersion 
light microscopy. The number of infected macrophages and the 
average number of parasites per macrophage was determined 
in 200 cells. The results were expressed as the infection index, 
which is the percentage of infected macrophages multiplied by 
the average number of amastigotes per macrophage.
Data processing and statistics
All experiments were repeated at least three times in triplicate 
wells. The results were expressed as the mean plus or minus 
the standard deviation. The Levene test was used to determine 
the homogeneity of the variances. Parametric tests (Student’s 
t-test, analysis of variance) were used to evaluate the results 
for significant differences. Data were analyzed using SPSS 
software (v 16.0 for Windows; SPSS Inc, Chicago, IL) and 
P , 0.05 values were considered statistically significant.
Results
characterization of Ag-NPs
The particle size analysis and distribution of the nanoparticles 
was performed by transmission electron microscopy and DLS 
analysis. Transmission electron microscope (TEM) images 
and results of the DLS analysis are presented in Figure 1. 
TEM images of the aqueous dispersion show the particle 
size to be in the range of 10–40 nm (Figure 1A and B). It 
is also clearly seen that Ag-NPs were round-shaped with a 
smooth surface morphology and tended to form clumps. DLS 
analysis of an aqueous dispersion revealed the formation of 
nanoparticles with an average hydrodynamic diameter of 
approximately 65 nm (Figure 1C).
effects of Ag-NPs on morphology, 
metabolic activity, proliferation,  
and infectivity of L. tropica promastigotes
Morphology
The promastigotes in the control group not exposed to 
  Ag-NPs or UV light were seen to retain their shape and 
organelles (nucleus, kinetoplast, flagella) when viewed after 
Giemsa staining (Figure 2A). However, when exposed to Ag-
NPs in the dark, L. tropica promastigotes lost their shape and 
their internal organelles were not distinguishable (  Figure 2B). 
Similarly, when exposed to Ag-NPs in UV light, promastig-
otes had an atypical appearance, owing to disruption of their 
membranes (Figure 2C). Furthermore, as seen in Figure 2B 
and C, the number of cells decreased significantly, whether 
exposed to Ag-NPs in the dark or to Ag-NPs in UV light, 
when compared with the control groups.
Metabolic activity (viability)
The effect of Ag-NPs on metabolic activity of L. tropica 
promastigotes at different concentrations (25, 50, 100, 150, 
and 200 µg/mL) was determined microscopically and quanti-
tatively by the MTT method in the dark and under UV light. 
Figure 3A shows the occurrence of formazan crystals (which 
are the signature of metabolic activity) in the control group 
held in the dark. Formazan crystal formation in promas-
tigotes was very intense under these conditions. However, 
exposure to Ag-NPs in the dark resulted in the formation of 
fewer formazan crystals than in the control group. A low rate 
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Figure  1  characterization  of  silver  nanoparticles:  (A)  transmission  electron 
microscope (TeM) image at the scale of 20 nm, (B) TeM image at the scale of 50 nm, 
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of formazan crystal formation was especially noticeable 
on exposure to nanoparticle concentrations of 150 µg/mL 
(Figure 3B) and 200 µg/mL (Figure 3C).
Similar to exposure in the dark, metabolic activity of the 
L. tropica promastigotes decreased after exposure to nanopar-
ticles under UV light. Even though high amounts of formazan 
crystals were formed when parasites were exposed to UV light 
alone (Figure 4A), in experimental groups when parasites 
were exposed to high concentrations of Ag-NPs (150 µg/mL 
and 200 µg/mL) in addition to UV light, the rate of formation 
of formazan crystals was very low (Figure 4B and C).
The quantitative effects of Ag-NPs on the metabolic activ-
ity of L. tropica promastigotes were also studied. The effects 
of different concentrations of Ag-NPs in dark conditions are 
shown in Figure 5: with rising concentrations of Ag-NPs, the 
metabolic activity of L. tropica parasites decreased. In com-
parison with the control group, it was obvious that each con-
centration of Ag-NPs negatively affected the metabolic activity 
of L. tropica promastigotes. As a result, Ag-NPs showed the 
biggest suppressive effect on parasites at a concentration 
of 200 µg/mL, and at the same concentration the metabolic 
activity values of L. tropica promastigotes decreased nearly 
twofold, in contrast to the control group (P , 0.05).
Results of the study on the effects of Ag-NPs on the 
metabolic activity of L. tropica promastigotes under UV light 
showed that the cell viability values also decreased gradu-
ally with the increase in Ag-NP concentrations (Figure 5). 
The biggest effect on the metabolic activity of promastigotes 
under UV light was seen in the highest concentration of Ag-
NPs (200 µg/mL). These results demonstrated a different 
effect of Ag-NPs on cell viability of L. tropica promastigotes 
under the dark condition and under application of UV light. 
Figure 2 Microscopic view of parasites (A) in the control group (not exposed to 
silver nanoparticles [Ag-NPs]), (B) in the group exposed to Ag-NPs in the dark, 
and (C) in the group exposed to Ag-NPs under ultraviolet light (giemsa staining, 
magnification 100×).
Figure 3 Microscopic views  of the effects of silver  nanoparticles (Ag-NPs) on 
metabolic activity of Leishmania tropica promastigotes in the dark: (A) parasites in 
the control group (not exposed to Ag-NPs), (B) the cytopathic effects of Ag-NPs 
at 150 µg/mL, and (C) the cytopathic effects of Ag-NPs at 200 µg/mL. Arrows in 
(A) indicate the formation of formazan crystals and in (B) and (C) indicate the 
clusters of Ag-NPs (magnification 40×).
Figure 4 Microscopic views  of the effects of silver  nanoparticles (Ag-NPs) on 
metabolic activity of Leishmania parasites under ultraviolet light: (A) parasites in 
the control group (not exposed to Ag-NPs), (B) the cytopathic effects of Ag-NPs 
at 150 µg/mL, and (C) the cytopathic effects of Ag-NPs at 200 µg/mL. Arrows in 
(A) indicate the formation of formazan crystals and in (B) and (C) indicate the 
clusters of Ag-NPs (magnification 40×).International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Compared with the control group, the metabolic activity 
values of the parasites exposed to high concentrations of 
Ag-NPs decreased approximately twofold in the dark and 
6.5-fold under UV light (both P values ,0.05).
Proliferation
The effects of Ag-NPs on the proliferation of L. tropica 
promastigotes were investigated in the dark and under UV 
light. Since the authors observed that metabolic activity 
values of parasites decreased conversely with the increase 
in the concentration of Ag-NPs, in this experiment the 
authors used a concentration of 200 µg/mL of Ag-NPs, 
which demonstrated the most significant effect on meta-
bolic activity. To make determinations, promastigotes were 
counted in control and experimental groups at 24, 48, and 
72 hours of incubation. In Figure 6, a significant decrease 
in the number of parasites is seen in each group, in com-
parison with the control groups, after exposure to Ag-NPs. 
This effect was observed during all analyzed incubation 
periods. As Figure 6 clearly shows, the effects of Ag-NPs 
on the proliferation of promastigotes under UV light were 
more pronounced than they were in the dark (P , 0.05). In 
the experimental group exposed to both Ag-NPs and UV 
light, the number of parasites decreased nearly threefold 
compared with the control group held under UV light 
(P , 0.05). These results are an indicator of the effects of 
Ag-NPs on the growth of Leishmania parasites in the dark 
and especially under UV light.
Infectivity
The effects of Ag-NPs on infectivity of L. tropica parasites 
were also investigated, since infectivity is one of the important 
biological parameters of Leishmania parasites. Figure 7A 
shows that the promastigotes not exposed to nanoparticles or 
UV light had infected macrophages actively, and, consequently, 
promastigotes had transformed into amastigote forms. Simi-
larly, promastigotes infected the macrophages in the control 
group exposed to UV light (Figure 7B). However,   Figure 7C 
0
II I III IV
Concentration
V
i
a
b
i
l
i
t
y
VV I
Dark
UV light
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
Figure 5 The effects of different concentrations of silver nanoparticles on metabolic 
activity of Leishmania tropica promastigotes both in the absence and in the presence 
of ultraviolet (UV) light (I, control group; II, 25 µg/mL; III, 50 µg/mL; IV, 100 µg/mL; 
V, 150 µg/mL; VI, 200 µg/mL).
0
II I III IV
N
u
m
b
e
r
 
o
f
 
p
a
r
a
s
i
t
e
s
 
(
/
m
L
)
24 h
48 h
72 h
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Figure 6 effects of silver nanoparticles (Ag-NPs) on the proliferation of Leishmania tropica promastigotes in the dark and under ultraviolet (UV) light in different incubation 
periods (I, parasites in control group in the dark; II, parasites exposed to Ag-NPs in the dark; III, parasites in control group exposed to UV light; IV, parasites exposed to 
Ag-NPs under UV light). Ag-NPs had significant effects on Leishmania parasites in the experiment groups compared with the control groups. The biggest effect was observed 
in the experiment group exposed to Ag-NPs and UV light.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2711
Antileishmanial effect and antiparasitic activity of silver nanoparticles
shows that L. tropica promastigotes exposed to Ag-NPs in the 
dark infected the macrophages less efficiently than they did in 
the control groups, while the promastigotes exposed to Ag-NPs 
with UV light (Figure 7D) did not infect the macrophages. 
These results indicate that infectivity ratios of L. tropica 
promastigotes decrease in association with their exposure to 
non-UV-exposed Ag-NPs, but they are totally inhibited when 
they were faced with UV-exposed Ag-NPs.
effects of Ag-NPs on L. tropica  
amastigotes
Primarily, toxicity assay for Ag-NPs was conducted on mac-
rophage cells in order to determine nontoxic concentrations of 
Ag-NPs. It was found that low concentrations such as 1, 5, and 
10 µg/mL had no toxic effects on macrophages in the dark or 
under UV light (data not shown). Therefore, the authors tested 
the antileishmanial effects of these nontoxic concentrations 
on L. tropica amastigotes that infected the macrophages, both 
in the presence and in the absence of UV light. According to 
infection index values, in dark conditions the inhibitory effects 
of Ag-NPs on amastigotes showed a concentration-dependent 
increase compared with the control groups (Figure 8). The 
infection index of amastigotes in the control group held in 
the dark was 107, while it was 68, 48, and 42 for amastigotes 
exposed to 1, 5, and 10 µg/mL of Ag-NPs, respectively. Results 
were similar in the presence of UV light, and the infection 
index inversely correlated with Ag-NP concentrations. Also, 
it was demonstrated that Ag-NPs had more inhibitory effect on 
amastigotes under UV light when compared with dark condi-
tions (Figure 8). Infection index values for amastigotes were 
evaluated as 35, 23, and 15 when amastigotes were exposed 
to 1, 5, and 10 µg/mL of Ag-NPs, respectively, while it was 
85 for the control group exposed to UV light.
Figure 7 Microscopic views of macrophages infected or not infected by parasites 
after being stained with giemsa. Leishmania tropica promastigotes (A) in the control 
group held in the dark and (B) in the control group exposed to ultraviolet (UV) 
light  infected  the  macrophages.  (C)  L.  tropica  promastigotes  exposed  to  silver 
nanoparticles (Ag-NPs) in the dark also infected macrophages, but their infectivity 
was  very  low  compared  with  the  control  groups.  (D)  L.  tropica  promastigotes 
exposed to Ag-NPs under UV light did no infect the macrophages. (Arrows indicate 
macrophage-infected parasites.)
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Discussion
The present study is the first to investigate the antileishmanial 
effects of UV-exposed and non-UV-exposed Ag-NPs on vari-
ous cellular biological parameters of L. tropica parasites. It 
was determined that both UV-exposed and non-UV-exposed 
Ag-NPs demonstrated antileishmanial effects by inhibiting 
growth, metabolic activity, and infectivity of promastigotes 
by preventing survival of amastigotes inside host cells. It was 
also determined that this antileishmanial effect increased 
further under UV light. Despite there being several studies 
about their antibacterial, antiviral, and antifungal activities, 
no study has been reported regarding the antileishmanial 
effect of Ag-Nps on L. tropica parasites. Moreover, although 
there are limited numbers of studies demonstrating the syn-
ergistic antibacterial and antiviral effects of silver ions and 
UV light together, this study is the first to show increased 
antimicrobial effects of Ag-NPs under UV light.
Some researchers have investigated the antibacterial 
effects of Ag-NPs. It has been shown that Ag-NPs have dif-
ferent mechanisms for killing bacteria cells. Ag-NPs have the 
ability to bind strongly to sulfur- and phosphor-containing 
compounds34 and, because of this property, they can damage 
the bacterial cell membrane by impairing sulfur-containing 
proteins. Ag-NPs can penetrate the bacteria and can dam-
age sulfur-containing enzymes and phosphor-containing 
DNA. Ag-NPs are also known to accumulate heavily within 
mitochondria and are reported to impair mitochondrial func-
tion via oxidative stress.35,36 It is well known that adenosine 
triphosphate (ATP) synthesis ceases when mitochondrial 
enzymes are damaged. Therefore, it is thought that their 
antibacterial effects are due to the ability to inhibit ATP 
synthesis. Another antimicrobial mechanism of Ag-NPs is 
the releasing of silver ions.37,38 These ions contribute to cell 
death by producing high amounts of ROS.39,40 After penetrat-
ing the bacterial cytoplasm, silver ions also form complexes 
with cysteine groups of enzymes. These complexes prevent 
the enzymatic functions of proteins. According to this 
  mechanism, silver ions exhibit antibacterial effects.41–45
The main reason for using Ag-NPs in this study was their 
capacity to produce ROS, which Leishmania parasites are 
known to be susceptible to. Also, the authors hypothesized 
that their wide surface areas, small sizes, and their ability to 
bind sulfur- and phosphor-containing groups may lead to an 
increase in their antileishmanial effects. In parallel with this 
opinion, it was observed that Ag-NPs decreased the metabolic 
activity and proliferation values of parasites compared with 
the control groups. However, more extensive effects were 
seen in Leishmania parasites exposed to Ag-NPs and UV 
light together.
Butkus et al33 explored for the first time the synergistic 
effects of silver ions and UV light together on a RNA virus, 
and demonstrated that RNA viruses were not affected by 
UV light only but by silver ions and UV light giving rise 
to inactivation of viruses together. In light of this study, 
Kim et al46 explored the synergistic effects of silver ions 
and UV light on E. coli. It was demonstrated that UV 
irradiation substantially increased the effect of silver ions 
for inactivation of bacteria cells. It was suggested that this 
synergism was bound to the impact of UV light on silver-
cysteine complexes. It was posited that silver-cysteine 
complexes irradiated by UV light would generate mono-
sulfide radicals. These radicals can react with the other 
functional components and this enhances their impact on 
bacterial cell damage.46 On the other hand, while titanium 
dioxide nanoparticles gain photocatalytic features and have 
enhanced antimicrobial effects under UV light, reports on 
studies examining activation of Ag-NPs by exposure to 
UV light are lacking.47,48 However, in the present study, 
the authors first determined that the effects on parasites 
of Ag-NPs with UV light were more than the effects of 
Ag-NPs by themselves. These effects were demonstrated 
on various biological parameters relating to the parasite. 
Since Ag-NPs are known to have the ability to release silver 
ions, the authors consider the reason for Ag-NPs showing 
greater effects under UV light may be the demonstration of 
synergistic effects of silver ions released from Ag-NPs with 
UV light. Released silver ions may make complexes with 
cysteine groups of enzymes and proteins within parasites, 
and UV irradiation may also lead to monosulfur radical 
generation from the complex. This may lead to extra dam-
age within parasites, on top of that shown by silver ions 
alone within bacteria or viruses.
The results also show that live parasites lose their infec-
tion abilities following exposure to nanoparticles. This 
appears more significantly in parasites exposed to both Ag-
NPs and UV light. The authors consider the reason for this 
is the interaction of Ag-NPs with the surface of   parasites. 
It may be posited that Ag-NPs impair the structure of lipo-
phosphoglycan and glycoprotein 63 molecules that are found 
on the surface of parasites and which are responsible for the 
infection. The authors also propose that these molecules 
may be more seriously affected from ROS generated more 
intensively because of interactions between Ag-NPs and 
UV light, as described, and this may lead to inhibition of International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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parasite infection. This result indicates that Ag-NPs, alone 
or with UV light, can protect the host cells from Leishmania 
infection and make the parasites harmless, even though the 
parasites are still alive. Therefore, the authors consider a 
new approach, one that includes the application of Ag-NPs 
on vectors that carry infective Leishmania promastigotes, 
may be offered in the near future, and that this may prevent 
the disease from spreading.
Results also demonstrated that Ag-NPs had inhibitory 
effects on amastigote forms of Leishmania parasites even in 
low concentrations that had no toxic effects on macrophages. 
Interestingly, Ag-NP concentrations that had no antileish-
manial effects on promastigotes significantly inhibited the 
survival of amastigotes inside host macrophage cells. This 
indicates that amastigotes are more sensitive to Ag-NPs 
than promastigotes. The authors consider that it can be 
related to the action of macrophages following nanoparticle 
exposure. Macrophages may produce more lytic enzymes 
or nitric oxide to inhibit Leishmania parasites, depending 
on their interactions with nanoparticles. Also, it may be 
posited that amastigotes exposed to nanoparticles may not 
negatively affect the ROS production by macrophages, and 
that these host cells may contribute to inhibition of parasites 
by releasing more ROS in addition to the efficacy mecha-
nism of nanoparticles. The results clearly show there is no 
need to apply high concentrations of Ag-NPs for inhibiting 
amastigotes, and this may be very promising for the treat-
ment of leishmaniasis.
Conclusion
This study was the first time that Ag-NPs were   determined 
to possess antileishmanial effects on L. tropica para-
sites through examining their effects on various cel-
lular   parameters of promastigote and amastigote forms. 
Results demonstrate that use of Ag-NPs may represent a 
future alternative to current antileishmanial drugs. Since 
leishmaniasis is spreading rapidly worldwide and because 
antileishmanial drugs have several disadvantages, the 
authors posit that treatment based on Ag-NPs may have 
a very important role in overcoming leishmaniasis. For 
this reason, it is suggested that new studies on this issue 
are urgently required. Additionally, the authors believe 
that determination of enhanced antiparasitic effects of 
Ag-NPs under UV light may be very useful for further 
antimicrobial applications, as this combination provides 
more effective elimination of infectious agents such as 
Leishmania parasites.
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